The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of ex vivo expanded cord blood natural killer cells for multiple myeloma.
 
Nina Shah
Stock and Other Ownership Interests - Indapta Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Indapta Therapeutics; Sanofi; Takeda; TeneoBio
Research Funding - Bluebird Bio; Celgene; Janssen
 
Rohtesh Mehta
No Relationships to Disclose
 
Li Li
No Relationships to Disclose
 
Jessica Mccarty
No Relationships to Disclose
 
Indreshpal Kaur
No Relationships to Disclose
 
Robert Z. Orlowski
No Relationships to Disclose
 
Laurence Cooper
Employment - ZIOPHARM Oncology
Stock and Other Ownership Interests - Immatics; Intrexon; Taro; ZIOPHARM Oncology
Research Funding - Intrexon; ZIOPHARM Oncology
Patents, Royalties, Other Intellectual Property - Intrexon; MD Anderson Cancer; Sangamo Bioscience (I); ZIOPHARM Oncology
 
Dean Anthony Lee
Leadership - Cyto-Sen Therapeutics
Stock and Other Ownership Interests - Courier Therapeutics; Cyto-Sen Therapeutics
Honoraria - Miltenyi Biotec
Consulting or Advisory Role - Courier Therapeutics; Cyto-Sen Therapeutics; Intellia Therapeutics; Jazz Pharmaceuticals; Merck Sharp & Dohme; Shire; ZIOPHARM Oncology
Patents, Royalties, Other Intellectual Property - US 60/925,830, PCT/US2008/061342 US 62/404,520 US 62/623,682 US 18/20,187
Travel, Accommodations, Expenses - Cyto-Sen Therapeutics; Merck Sharp & Dohme; Shire
 
Kai Cao
No Relationships to Disclose
 
Simrit Parmar
No Relationships to Disclose
 
Chitra Hosing
No Relationships to Disclose
 
Sairah Ahmed
No Relationships to Disclose
 
Yago Nieto
No Relationships to Disclose
 
Qaiser Bashir
Stock and Other Ownership Interests - Kite, a Gilead company
Consulting or Advisory Role - Spectrum Pharmaceuticals; Takeda
Research Funding - Celgene; Takeda (Inst)
 
Krina K. Patel
Honoraria - Targeted Oncology
Consulting or Advisory Role - Amgen; Celgene; Hikma Pharmaceuticals; Juno Therapeutics
Research Funding - Celgene; Janssen; poseida therapeutics; Takeda
 
Catherine Bollard
Consulting or Advisory Role - Cellectis; NexImmune; Torque
 
Muzaffar H. Qazilbash
No Relationships to Disclose
 
Richard E. Champlin
No Relationships to Disclose
 
Katayoun Rezvani
No Relationships to Disclose
 
Elizabeth J. Shpall
No Relationships to Disclose